Advertisement
Advertisement
WVE
Wave Life Sciences Ltd. Ordinary Shares
7.18
USDSponsored
-0.06
-0.83%
May 08, 16:00 UTC -4
Closed
After-Market
7.25
+0.07
+0.91%
WVE Earnings Reports
Positive Surprise Ratio
WVE beat 10 of 42 last estimates.
24%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$8.35M
/-$0.32
Implied change from Q1 26 (Revenue/ EPS)
-78.17%
/+146.15%
Implied change from Q2 25 (Revenue/ EPS)
-4.04%
/+3.23%
Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue
On Apr 28, 2026, WVE reported earnings of -0.13 USD per share (EPS) for Q1 26, beating the estimate of -0.33 USD, resulting in a 60.74% surprise. Revenue reached 38.25 million, compared to an expected 9.21 million, with a 315.26% difference. The market reacted with a +8.36% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 8.35 million USD, implying an increase of 146.15% EPS, and decrease of -78.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
FAQ
What were Wave Life Sciences Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.13, beating estimates by 60.74%, and revenue of $38.25M, 315.26% above expectations.
How did the market react to Wave Life Sciences Ltd. Ordinary Shares's Q1 2026 earnings?
The stock price moved up 8.36%, changed from $6.94 before the earnings release to $7.52 the day after.
When is Wave Life Sciences Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for Wave Life Sciences Ltd. Ordinary Shares's next earnings report?
Based on 12
analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.32 and revenue of $8.35M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement